Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.54 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 3/20 | 0.34 |
| ▸ | MMP9 | P14780 | 3/20 | 0.34 |
| ▸ | ALB | P02768 | 2/20 | 0.34 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
| ▸ | MMP12 | P39900 | 2/20 | 0.34 |
| ▸ | MMP14 | P50281 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL71086 | 0.95 | GLP1R (0.50) | GLP1RFOLH1GLO1MMP2MMP9 | |
| SCHEMBL14240744 | 0.95 | GLP1R (0.50) | GLP1RFOLH1GLO1MMP2MMP9 | |
| SCHEMBL21440827 | 0.95 | GLP1R (0.50) | GLP1RFOLH1GLO1MMP2MMP9 | |
| SCHEMBL21440821 | 0.93 | GLP1R (0.48) | GLP1RFOLH1MMP2MMP9MMP8 | |
| SCHEMBL14241031 | 0.93 | GLP1R (0.48) | GLP1RFOLH1MMP2MMP9MMP8 | |
| SCHEMBL71085 | 0.93 | GLP1R (0.48) | GLP1RFOLH1MMP2MMP9MMP8 | |
| SCHEMBL25662184 | 0.91 | GLP1R (0.56) | GLP1RNOD1FOLH1GLO1 | |
| SCHEMBL25662193 | 0.91 | GLP1R (0.56) | GLP1RNOD1FOLH1GLO1 | |
| SCHEMBL23874254 | 0.91 | GLP1R (0.56) | GLP1RNOD1FOLH1GLO1 | |
| SCHEMBL24253206 | 0.89 | GLP1R (0.60) | GLP1RNOD1FOLH1GLO1ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022032353-A1 | RADIOPHARMACEUTICALS, USES THEREOF, AND METHODS FOR THE PRODUCTION THEREOF | Clarity Pharmaceuticals Ltd (AU) | 2022-02-17 | — | — | WO | disclosed |